Trial Profile
Phase 2, Double-Blind, Parallel-group Study of S-2367 in Obese Patients with Hypertension and Dyslipidemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Velneperit (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Shionogi
- 24 May 2016 New trial record